HEMA’s Inaugural Report Misses the Mark for U.S. Patients Read more about HEMA’s Inaugural Report Misses the Mark for U.S. Patients
American Patients vs Foreign Governments — A Tale of 2 Value Sets Read more about American Patients vs Foreign Governments — A Tale of 2 Value Sets
Patient Engagement in Managed Care Pharmacy: Putting Policy Into Practice Read more about Patient Engagement in Managed Care Pharmacy: Putting Policy Into Practice
New Commentary in JMCP — Patient Engagement in Managed Care Pharmacy: Putting Policy Into Practice Read more about New Commentary in JMCP — Patient Engagement in Managed Care Pharmacy: Putting Policy Into Practice
NPC Submits Comments to HEMA on Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies Read more about NPC Submits Comments to HEMA on Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies
Heavy on Price, Light on Access: ICER’s Launch Price and Access Report Misses the Mark Read more about Heavy on Price, Light on Access: ICER’s Launch Price and Access Report Misses the Mark
NPC Releases Updated Guiding Practices to Improve Patient-Centricity in Value Assessments Read more about NPC Releases Updated Guiding Practices to Improve Patient-Centricity in Value Assessments
Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States Read more about Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States